GlassScriptPhysician profile
Sandra Z Brothers
NPI 1124052121
$1,141.35
in general payments reported to CMS, 2019-2025
21 companies · $18.28 in 2025
The $18.28 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $433 · 2020: $39.99 · 2021: $115 · 2022: $75.09 · 2023: $340 · 2024: $120 · 2025: $18.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $350.87 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Hologic Sales and Service, LLC | $184.00 | 2019-2025 | Aptima, Acessa Provu System, Myosure Tissue Removal Device |
| Minerva Surgical, INC | $92.77 | 2021-2024 | |
| Smith+Nephew, INC. | $65.17 | 2019 | |
| Duchesnay USA Incorporated | $62.36 | 2019 | |
| Exeltis, USA INC. | $51.01 | 2019-2023 | Slynd |
| Astellas Pharma US INC | $45.15 | 2023 | Veozah, Myrbetriq |
| Janssen Pharmaceuticals, INC | $44.77 | 2023-2024 | Xarelto |
| Sumitomo Pharma America, INC. | $44.09 | 2023 | Myfembree |
| Myovant Sciences INC. | $32.57 | 2022 | |
| Therapeuticsmd, INC. | $20.76 | 2019 | |
| Davol INC. | $20.25 | 2020 | |
| Organon LLC | $16.49 | 2023 | Nexplanon |
| Sage Therapeutics, LLC | $16.08 | 2023 | |
| Acessa Health INC. | $15.24 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $15.02 | 2022 | |
| Merck Sharp & Dohme LLC | $14.33 | 2019 | |
| Allergan, INC. | $13.16 | 2019 | |
| Coopersurgical, INC. | $12.84 | 2019 | |
| Pfizer INC. | $12.73 | 2023 | |
| Meditrina | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Brothers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.